FierceCRO is moving to Mondays

FierceCRO isn't going anywhere--just shifting its schedule. From here on out, you can expect the latest in contract research and manufacturing news and analysis in your inbox each Monday, starting next week. Same coverage and features, different day. See you next week. -- Damian Garde (email | Twitter)

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.